Sign in

CIK 0001878313

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

MAIA Biotechnology, Inc.

Sign in to watch
Ticker
MAIA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 312-416-8592
Business address
444 WEST LAKE STREET, SUITE 1700, CHICAGO, IL, 60606
Open-market buys, last 90 days
$352,317
in 5 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$352,317. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Guerrero Ramiro +$252K Director 4 filings
  2. Vitoc Vlad +$100K Chief Executive Officer 1 filing

Reading 36 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-12-31 CHAOUKI STEVEN M Director Grant or award · Stock Options +15,418 15,418
2023-12-31 Theagene Jean-Manasse Director Grant or award · Stock Options +15,418 15,418
2023-09-30 Theagene Jean-Manasse Director Grant or award · Stock Options +8,378 8,378
2023-09-30 Luput Cristian Director Grant or award · Stock Options +8,378 8,378
2023-09-30 Louie Ngar Yee Director Grant or award · Stock Options +12,567 12,567
2023-09-30 Guerrero Ramiro Director Grant or award · Stock Options +8,378 8,378
2023-09-30 CHAOUKI STEVEN M Director Grant or award · Stock Options +8,378 8,378
2023-09-30 Smith Stan Director Grant or award · Stock Options +10,472 10,472
2023-06-30 CHAOUKI STEVEN M Director Grant or award · Stock Options +8,910 8,910
2023-06-30 Guerrero Ramiro Director Grant or award · Stock Options +8,910 8,910
2023-06-30 Louie Ngar Yee Director Grant or award · Stock Options +13,365 13,365
2023-06-30 Luput Cristian Director Grant or award · Stock Options +8,910 8,910
2023-06-30 Theagene Jean-Manasse Director Grant or award · Stock Options +8,910 8,910
2023-06-30 Smith Stan Director Grant or award · Stock Options +11,138 11,138
2023-05-31 Obrocea Mihail Chief Medical Officer Grant or award · Stock Options +87,495 87,495
2023-05-31 Vitoc Vlad Chief Executive Officer Grant or award · Stock Options +123,760 123,760
2023-05-31 MCGUIRE JOSEPH F Chief Financial Officer Grant or award · Stock Options +69,075 69,075
2023-05-31 Gryaznov Sergei Chief Scientific Officer Grant or award · Stock Options +75,982 75,982
2023-05-18 Guerrero Ramiro Director Purchase 10b5-1 +1,200 $2.47 $3K 312,672.04
2023-05-15 Luput Cristian Director Purchase 10b5-1 +3,000 $2.63 $8K 298,068

Page 10 of 14 · 270 trades